These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34097256)

  • 1. Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects.
    Trivedi A; Oberoi RK; Jafarinasabian P; Zhang H; Spring M; Flach S; Abbasi S; Dutta S; Lee E
    Clin Drug Investig; 2021 Jul; 41(7):647-652. PubMed ID: 34097256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects.
    Trivedi A; Mackowski M; Jafarinasabian P; Zhang H; Flach S; Terminello B; Bhatia A; Dutta S; Lee E
    Clin Drug Investig; 2021 Jul; 41(7):639-645. PubMed ID: 34110614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator.
    Trivedi A; Oberoi RK; Mackowski M; Jafarinasabian P; Zhang H; Flach S; Simiens MA; Terminello B; Abbasi S; Dutta S; Lee E
    Biopharm Drug Dispos; 2021 Jul; 42(7):319-328. PubMed ID: 34087948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects.
    Trivedi A; Malik FI; Mackowski M; Hutton S; Aoki M; Abbasi S; Dutta S; Lee E
    Eur J Drug Metab Pharmacokinet; 2021 Nov; 46(6):759-770. PubMed ID: 34415561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.
    Choi T; Komirenko AS; Riddle V; Kim A; Dhuria SV
    Clin Pharmacol Drug Dev; 2019 Aug; 8(6):818-826. PubMed ID: 30605260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
    Shibata M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1135-1141. PubMed ID: 32472157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects.
    Trivedi A; Sohn W; Jafarinasabian P; Zhang H; Terminello B; Flach S; Abbasi S; Dutta S; Lee E
    Clin Pharmacol Drug Dev; 2022 Jan; 11(1):129-133. PubMed ID: 34272833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model.
    Trivedi A; Sohn W; Kulkarni P; Jafarinasabian P; Zhang H; Spring M; Flach S; Abbasi S; Wahlstrom J; Lee E; Dutta S
    Clin Transl Sci; 2021 Nov; 14(6):2510-2520. PubMed ID: 34415673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil.
    Trivedi A; Oberoi RK; Mackowski M; Jafarinasabian P; Zhang H; Flach S; Hutton S; Abbasi S; Dutta S; Lee E
    Clin Pharmacol Drug Dev; 2021 Dec; 10(12):1442-1451. PubMed ID: 34107172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil.
    Trivedi A; Oberoi RK; Jafarinasabian P; Zhang H; Flach S; Abbasi S; Dutta S; Lee E
    Clin Pharmacokinet; 2021 Aug; 60(8):1041-1048. PubMed ID: 33768487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects.
    Trivedi A; Sohn W; Hsu CP; Jafarinasabian P; Zhang H; Hutton S; Flach S; Abbasi S; Dutta S; Lee E
    Clin Pharmacol Drug Dev; 2022 Mar; 11(3):388-396. PubMed ID: 34634185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
    Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
    Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug-Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open-Label Studies in Healthy Subjects.
    Trivedi A; Malik FI; Jafarinasabian P; Zhang H; Flach S; Abbasi S; Dutta S; Lee E
    Clin Pharmacol Drug Dev; 2022 Feb; 11(2):185-193. PubMed ID: 34145992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
    Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Drug-Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2- and MATE1-Mediated Transport of Metformin in Healthy Participants.
    Bhardwaj R; Morris B; Matschke K; Bertz R; Croop R; Liu J
    Clin Pharmacol Drug Dev; 2024 May; 13(5):465-473. PubMed ID: 38174905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
    Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Sotorasib on the Pharmacokinetics and Pharmacodynamics of Metformin, a MATE1/2K Substrate, in Healthy Subjects.
    Vuu I; Wahlstrom J; Houk BE
    Clin Pharmacokinet; 2023 Feb; 62(2):267-275. PubMed ID: 36529835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.
    Yoon H; Cho HY; Yoo HD; Kim SM; Lee YB
    AAPS J; 2013 Apr; 15(2):571-80. PubMed ID: 23417334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.